InsidersTradesSigma
카나프테라퓨틱스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 카나프테라퓨틱스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 카나프테라퓨틱스 has logged 19 insider filings. Market capitalisation: €164.8bn. The latest transaction was disclosed on 22 May 2026 (Purchase). Among the most active insiders: 김동건. Every trade is free.
18
Insider Decl.
n/a
Thresholds
€334,253
16 ops.
Buy Volume
n/a
1 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 May 2026
Declarations19 total
Other
Other(filed)
752,163 sharesKRXDART:20260323000331
5,013,135 sharesKRXDART:20260317000652
ShareKRXDART:20260317000615
19 of 19 declarations
About 카나프테라퓨틱스
Kanap Therapeutics is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.